COGNITION THERAPEUTICS INC (CGTX)
US19243B1026 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.79M | -21.40M | -11.72M | -7.84M | -4.84M | |||
| Depreciation Amortization | 96.00K | 80.00K | 90.00K | 100.00K | 80.00K | |||
| Change In Working Capital | 4.85M | -940.00K | 2.84M | 3.07M | 570.00K | |||
| Other non cash items | 4.83M | 3.72M | 5.15M | 1.24M | 1.09M | |||
| OPERATING CASH FLOW | -16.02M | -18.53M | -3.63M | -3.43M | -3.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -147.00K | -170.00K | -30.00K | -10.00K | -140.00K | |||
| INVESTING CASH FLOW | -147.00K | -170.00K | -30.00K | -10.00K | -140.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -811.00K | -1.40M | -270.00K | 5.81M | 2.83M | |||
| Stock Issued/Repurchased | 5.33M | 6.94M | 44.53M | 50.00K | 0.00 | |||
| Other Financing Activity | N/A | 0.00 | 8.94M | -90.00K | -30.00K | |||
| FINANCING CASH FLOW | 4.52M | 5.55M | 53.20M | 5.77M | 2.79M | |||
| Exchange Rate Effect | 4.00K | 0.00 | -10.00K | -20.00K | -60.00K | |||
| CHANGE IN CASH | -11.64M | -13.15M | 49.53M | 2.31M | -510.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.02M | -18.53M | -3.63M | -3.43M | -3.10M | |||
| Capital Expenditure | -147.00K | -170.00K | -30.00K | -10.00K | -140.00K | |||
| FREE CASH FLOW | -16.16M | -18.70M | -3.66M | -3.44M | -3.24M | |||
All data in USD